Oncolytics Biotech
Price & Volume
Stats
See more52W Range | $0.32-$1.51 |
Market Cap | $127.7M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.30 |
News
See moreYahoo Finance • 10 days ago
Oncolytics Schedules Type C Meeting With FDA For Pelareorep In Anal Cancer
Yahoo Finance • 28 days ago
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
Yahoo Finance • 2 months ago
THE INFRASTRUCTURE REALIGNMENT: 5 Stocks Positioning for the 2026 Supply Imperative
Yahoo Finance • 2 months ago
Oncolytics surges on Fast Track status for pelareorep in colorectal cancer
About
CEO | Mr. Jared Kelly J.D., L.L.M. |
Address | 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |
